Company news
Renalytix Plc (LSE:RENX) news
Renalytix Plc news releases on 6ix. Latest, Jan 13, 2021: Finalization of MCIT rule for coverage pathway
Press releases — page 5
Finalization of MCIT rule for coverage pathway
January 13, 2021
Partnership Between RenalytixAI and DaVita
January 5, 2021
RENX to present at 39th JP Morgan Healthcare Conf.
January 4, 2021
Partnership with National Kidney Foundation
December 2, 2020
Financial Results for First Quarter of FY 2021
November 25, 2020
Stifel 2020 Healthcare Conference
November 13, 2020
Posting of Annual Report & Accounts &Notice of AGM
November 2, 2020
Full Year Report
October 27, 2020
Verici Dx - Intention to admit to trading on AIM
October 13, 2020
California Commercial Lab Certification Recieved
September 22, 2020
KidneyIntelX clinical testing launch
September 18, 2020
Grant of Purchase Rights and Verici update
September 2, 2020
Submission seeking FDA Clearance of KidneyIntelX
August 26, 2020
RenalytixAI to Collaborate with AstraZeneca
August 21, 2020
KidneyIntelX in Multi-Center Study
August 3, 2020
Over allotment option exercise
July 27, 2020
Closing of Global Offering and resulting TVR
July 21, 2020
Pricing of Global Offering
July 17, 2020
Launch of Global Offering and application to list
July 13, 2020
Approval of distribution of shares in Verici Dx
July 8, 2020
KidneyIntelX study accepted for publication
July 1, 2020
University of Michigan Partnership & Data Sharing
June 30, 2020
Proposed Board changes; Circular & Notice of GM
June 25, 2020
KidneyIntelXT receives New York State approval
June 12, 2020
Confirmation of reduction of capital
June 10, 2020
JV for COVID-19 antibody test scaled production
May 20, 2020
Proposed dual-listing on Nasdaq
May 18, 2020
Removal of US Securities Law Restrictions
May 5, 2020
Update re. potential demerger of FractalDx
April 28, 2020
Utah Lab Facility Achieves ISO 13485 Certification
April 27, 2020
KidneyIntelX used in Mount Sinai COVID-19 study
April 20, 2020
Provider network agreement for KidneyIntelXT
April 15, 2020
Medicare provider number
April 1, 2020
Presentation of KidneyIntelX Health Economics Data
March 27, 2020
Podium Presentation and Publication for Data
March 24, 2020
New commercial testing facility opens in Utah
January 8, 2020
CMS Pricing Determination becomes effective
January 3, 2020
Medicare sets US national price for KidneyIntelX
December 3, 2019
Grant of Options
November 21, 2019
RenalytixAI attending City Event for Kidney Health
November 19, 2019
Partnership with CDPHP on KidneyIntelX
October 17, 2019
Board appointment
October 14, 2019
US CPT® reimbursement code effective
October 1, 2019
Update on non-executive director appointment
September 30, 2019
Final Results
September 3, 2019
Expansion of Chronic Kidney Disease Advisory Board
August 6, 2019
Thomas McLain Appointed as President and CCO
July 29, 2019
Result of Placing & Total Voting Rights
July 23, 2019
US Exec Order on Advancing American Kidney Health
July 12, 2019
Positive Interim Results for Validation Study
July 9, 2019